SEC Tracker
Get the app

Traws Pharma TRAW

Traws Pharma: Private placement notice

Private placement notice

Form
D
Filed
Importance
Routine
  1. Issuer: Traws Pharma, Inc.
  2. Jurisdiction: Delaware
  3. Related persons include Iain Dukes (CEO & Director), Charles Parker (CFO), and Jack Stover (Chair)

Written from the Form D on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Traws Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Mannatech MTEX public float $10M, Jun 30, 2025
  2. LeonaBio ATHA public float $10M, Jun 30, 2025
  3. BioCardia BCDA public float $10M, Jun 30, 2025
  4. Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025
  5. Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.